Stockscreener 앱 받기
2.06
11.59%
-0.27
시간 외 거래:
2.10
0.04
+1.94%
전일 마감가:
$2.33
열려 있는:
$2.33
하루 거래량:
39,913
Relative Volume:
0.12
시가총액:
$5.07M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-15.29%
1개월 성능:
-24.26%
6개월 성능:
-88.00%
1년 성능:
-96.31%
1일 변동 폭
$2.06
$2.33
1주일 범위
$2.06
$2.68
52주 변동 폭
$2.06
$82.00
Autonomix Medical Inc Stock (AMIX) Company Profile
명칭
Autonomix Medical Inc
전화
832-277-7816
주소
21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS
AMIX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AMIX
Autonomix Medical Inc
|
2.06 | 5.07M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
130.28 | 225.95B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
96.42 | 142.29B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
363.84 | 138.83B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
91.51 | 117.34B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
68.51 | 40.28B | 5.72B | 4.17B | 259.90M | 6.97 |
Autonomix Medical Inc 주식(AMIX)의 최신 뉴스
Autonomix stock plunges to 52-week low of $2.23 amid market challenges By Investing.com - Investing.com South Africa
Autonomix Medical (NASDAQ:AMIX) versus Adagio Medical (NASDAQ:ADGM) Head-To-Head Review - Defense World
Autonomix Medical, Inc. Announces Abstract Highlighting Technology And Early Proof-Of-Concept Study Results Accepted At The Society Of Interventional Radiology (SIR) Annual Scientific Meeting - MENAFN.COM
Autonomix Medical, Inc. Announces Abstract Highlighting Technology and Early Proof-of-Concept Study Results Accepted at the Society of Interventional Radiology (SIR) Annual Scientific Meeting - GlobeNewswire
Can This New Technology Transform Pancreatic Cancer Pain Management? Major Conference Takes Notice - StockTitan
Autonomix stock hits 52-week low at $2.54 amid steep annual decline - Investing.com
Autonomix Medical, Inc. (NASDAQ: AMIX) to Present at the LSI USA '25 Emerging Medtech Summit - The Manila Times
Can Autonomix Medical's Nervous System Tech Disrupt the Medtech Landscape? CEO Presents Next March - StockTitan
Autonomix Medical, Inc. Selected for Podium Presentation at the 2025 CRT Annual Meeting - GlobeNewswire
Can This New Catheter Technology Transform Cancer Pain Treatment? First Clinical Results Revealed - StockTitan
Autonomix Medical to Showcase Catheter-Based Technology and Clinical Trial Findings at 2025 CRT Annual Meeting - Nasdaq
Autonomix Medical, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference - GlobeNewswire
Head-To-Head Contrast: KORU Medical Systems (NASDAQ:KRMD) & Autonomix Medical (NASDAQ:AMIX) - Defense World
AMIXAutonomix Medical Inc Latest Stock News & Market Updates - StockTitan
Autonomix Medical, Inc. Participates in the Virtual Investor 'Top 5 for '25” On-Demand Conference - The Manila Times
Can These 5 Growth Drivers Make Autonomix Medical the Next Big MedTech Success Story? - StockTitan
Autonomix Medical Announces Third Quarter Fiscal Year 2025 Financial Results and Operational Highlights - Defense World
Autonomix Medical reports net loss of USD 2.7M in Q3 2025 - Medical Buyer
Head-To-Head Survey: Autonomix Medical (NASDAQ:AMIX) and Profound Medical (NASDAQ:PROF) - Defense World
AUTONOMIX MEDICAL Earnings Results: $AMIX Reports Quarterly Earnings - Nasdaq
Autonomix Medical, Inc. Reports Third Quarter Fiscal Year 2025 Financial Results and Provides a Corporate Update - The Manila Times
Autonomix Secures $10M War Chest, Accelerates Revolutionary Cancer Pain Treatment Development - StockTitan
U.S. Patent Awarded to Autonomix for Cancerous Tumor Treatment - MPO-mag
Autonomix Medical Hires Regulatory Affairs and Quality VP - MPO-mag
Short Interest in Autonomix Medical, Inc. (NASDAQ:AMIX) Grows By 159.2% - Defense World
Autonomix Medical, Inc. Announces Release of the Next CEO Corner Segment -January 27, 2025 at 11:05 am EST - Marketscreener.com
Financial Survey: Autonomix Medical (NASDAQ:AMIX) & Becton, Dickinson and Company (NYSE:BDX) - Defense World
Autonomix Medical, Inc. Chief Executive Officer Participated in Virtual Investor EventAutonomix Medical, Inc. (NASDAQ: AMIX) recently disclosed in an 8-K filing that its Chief Executive Officer, Brad Hauser, took part in the “Virtual Investor Closing - Defense World
Final Design Set for Autonomix Medical’s RF Ablation Catheter - MPO-mag
Autonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner Segment - The Manila Times
Autonomix Medical CEO Shares Key Insights from JPM Healthcare Conference - StockTitan
Autonomix Medical finalizes ASIC microchip design - MSN
Autonomix Medical finalizes ASIC microchip design By Investing.com - Investing.com Canada
Autonomix Medical, Inc. Finalizes Design of ASIC Microchip for Sensing Technology Catheter for Use in Humans, - EIN News
Autonomix Medical, Inc. Finalizes Design of ASIC Microchip - GlobeNewswire
Autonomix Medical Locks ASIC Microchip Design, Advances Toward Pancreatic Cancer Pain Treatment - StockTitan
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Autonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell Series - The Manila Times
Autonomix Medical CEO to Present Company Vision at Virtual Investor Closing Bell Series - StockTitan
Autonomix Medical, Inc. Announces Abstract Highlighting - GlobeNewswire
Autonomix Medical to Present First Clinical Data on Novel Pancreatic Cancer Pain Treatment at SIO 2025 - StockTitan
Autonomix Medical Shares Rise on New Patent for Cancer Treatment - MarketWatch
What's Going On With Autonomix Medical Stock Monday? - Benzinga
Autonomix granted U.S. patent for catheter-based technology - TipRanks
Autonomix Medical, Inc. Announces U.S. Patent Granted - GlobeNewswire
Autonomix Medical Patents Breakthrough Cancer Pain Treatment with 3000x Greater Sensitivity - StockTitan
Autonomix Medical CEO Unveils Strategic Vision in Latest Corporate Update - StockTitan
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial with Appointment of Vice President, Regulatory Affairs and Quality - The Manila Times
Autonomix Medical, Inc. Drives Towards U.S. Pivotal Trial - GlobeNewswire
Autonomix Medical Inc (AMIX) 재무 분석
Autonomix Medical Inc (AMIX)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
3.08%
0.71%
자본화:
|
볼륨(24시간):